Your browser doesn't support javascript.
loading
Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial.
Zhong, Wen-Zhao; Yan, Hong-Hong; Chen, Ke-Neng; Chen, Chun; Gu, Chun-Dong; Wang, Jun; Yang, Xue-Ning; Mao, Wei-Min; Wang, Qun; Qiao, Gui-Bin; Cheng, Ying; Xu, Lin; Wang, Chang-Li; Chen, Ming-Wei; Kang, Xiao-Zheng; Yan, Wan-Pu; Liao, Ri-Qiang; Yang, Jin-Ji; Zhang, Xu-Chao; Liu, Si-Yang; Zhou, Qing; Wu, Yi-Long.
Afiliação
  • Zhong WZ; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
  • Yan HH; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
  • Chen KN; Peking University Cancer Hospital and Institute, 100142, Beijing, China.
  • Chen C; Fujian Medical University Union Hospital, 350001, Fuzhou, China.
  • Gu CD; First Affiliated Hospital of Dalian Medical University, 116011, Dalian, China.
  • Wang J; Peking University People's Hospital, 100044, Beijing, China.
  • Yang XN; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
  • Mao WM; Zhejiang Cancer Hospital, 310022, Hangzhou, China.
  • Wang Q; Zhongshan Hospital, 200032, Shanghai, China.
  • Qiao GB; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
  • Cheng Y; Guangzhou Liuhuaqiao Hospital, 510000, Guangzhou, China.
  • Xu L; Jilin Provincial Tumor Hospital, 130012, Changchun, China.
  • Wang CL; Jiangsu Cancer Institute and Hospital, 210009, Nanjing, China.
  • Chen MW; Tianjin Medical University Cancer Institute and Hospital, 300060, Tianjin, China.
  • Kang XZ; First Affiliated Hospital of Xi'an Jiaotong University, 710061, Xi'an, China.
  • Yan WP; Peking University Cancer Hospital and Institute, 100142, Beijing, China.
  • Liao RQ; Peking University Cancer Hospital and Institute, 100142, Beijing, China.
  • Yang JJ; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
  • Zhang XC; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
  • Liu SY; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
  • Zhou Q; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
  • Wu YL; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, 510080, Guangzhou, China.
Signal Transduct Target Ther ; 8(1): 76, 2023 02 24.
Article em En | MEDLINE | ID: mdl-36823150
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Revista: Signal Transduct Target Ther Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China